These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8827083)

  • 1. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
    Suzuki H; Akakura K; Komiya A; Aida S; Akimoto S; Shimazaki J
    Prostate; 1996 Sep; 29(3):153-8. PubMed ID: 8827083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor gene mutations in human prostate cancer.
    Suzuki H; Sato N; Watabe Y; Masai M; Seino S; Shimazaki J
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):759-65. PubMed ID: 8274409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
    Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
    Taplin ME; Rajeshkumar B; Halabi S; Werner CP; Woda BA; Picus J; Stadler W; Hayes DF; Kantoff PW; Vogelzang NJ; Small EJ;
    J Clin Oncol; 2003 Jul; 21(14):2673-8. PubMed ID: 12860943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Androgen receptor gene mutations in prostate cancer].
    Wang C; Uchida T
    Nihon Hinyokika Gakkai Zasshi; 1997 May; 88(5):550-6. PubMed ID: 9184448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiandrogen withdrawal syndrome].
    Akimoto S
    Nihon Rinsho; 1998 Aug; 56(8):2135-9. PubMed ID: 9750522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
    Gaddipati JP; McLeod DG; Heidenberg HB; Sesterhenn IA; Finger MJ; Moul JW; Srivastava S
    Cancer Res; 1994 Jun; 54(11):2861-4. PubMed ID: 8187068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy.
    Culig Z; Klocker H; Bartsch G; Hobisch A
    Am J Pharmacogenomics; 2001; 1(4):241-9. PubMed ID: 12083956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
    Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
    Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of androgen receptor gene in Japanese human prostate cancer.
    Watanabe M; Ushijima T; Shiraishi T; Yatani R; Shimazaki J; Kotake T; Sugimura T; Nagao M
    Jpn J Clin Oncol; 1997 Dec; 27(6):389-93. PubMed ID: 9438000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor gene mutations in human prostate cancer.
    Newmark JR; Hardy DO; Tonb DC; Carter BS; Epstein JI; Isaacs WB; Brown TR; Barrack ER
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6319-23. PubMed ID: 1631125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
    Yoshida T; Kinoshita H; Segawa T; Nakamura E; Inoue T; Shimizu Y; Kamoto T; Ogawa O
    Cancer Res; 2005 Nov; 65(21):9611-6. PubMed ID: 16266977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiandrogen withdrawal syndrome.
    Wirth MP; Froschermaier SE
    Urol Res; 1997; 25 Suppl 2():S67-71. PubMed ID: 9144890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
    Tilley WD; Buchanan G; Hickey TE; Bentel JM
    Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and characteristics of antiandrogen withdrawal syndrome in prostate cancer after treatment with chlormadinone acetate.
    Akakura K; Akimoto S; Furuya Y; Ito H
    Eur Urol; 1998; 33(6):567-71. PubMed ID: 9743699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
    Terada N; Shimizu Y; Yoshida T; Maeno A; Kamba T; Inoue T; Nakamura E; Kamoto T; Ogawa O
    Prostate; 2010 Feb; 70(3):252-61. PubMed ID: 19790238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor gene mutations in hormone-refractory prostate cancer.
    Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
    J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance.
    Paul R; Breul J
    Drug Saf; 2000 Nov; 23(5):381-90. PubMed ID: 11085345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
    Taplin ME; Bubley GJ; Shuster TD; Frantz ME; Spooner AE; Ogata GK; Keer HN; Balk SP
    N Engl J Med; 1995 May; 332(21):1393-8. PubMed ID: 7723794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.